LLY

1,010.59

-0.43%↓

JNJ

201.99

-0.22%↓

ABBV

225.56

-1.28%↓

UNH

330.44

-0.79%↓

AZN

90.29

+0.09%↑

LLY

1,010.59

-0.43%↓

JNJ

201.99

-0.22%↓

ABBV

225.56

-1.28%↓

UNH

330.44

-0.79%↓

AZN

90.29

+0.09%↑

LLY

1,010.59

-0.43%↓

JNJ

201.99

-0.22%↓

ABBV

225.56

-1.28%↓

UNH

330.44

-0.79%↓

AZN

90.29

+0.09%↑

LLY

1,010.59

-0.43%↓

JNJ

201.99

-0.22%↓

ABBV

225.56

-1.28%↓

UNH

330.44

-0.79%↓

AZN

90.29

+0.09%↑

LLY

1,010.59

-0.43%↓

JNJ

201.99

-0.22%↓

ABBV

225.56

-1.28%↓

UNH

330.44

-0.79%↓

AZN

90.29

+0.09%↑

Search

ResMed Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

257.38 2.19

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

250.67

Max

257.75

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-31M

349M

Pardavimai

-12M

1.3B

P/E

Sektoriaus vid.

25.449

80.03

Pelnas, tenkantis vienai akcijai

2.55

Dividendų pajamingumas

0.86

Pelno marža

26.096

Darbuotojai

10,600

EBITDA

-29M

503M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+20.3% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.86%

2.29%

Kitas dividendų mokėjimo data

2025-12-18

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.6B

36B

Ankstesnė atidarymo kaina

255.19

Ankstesnė uždarymo kaina

257.38

Naujienos nuotaikos

By Acuity

33%

67%

107 / 374 reitingas Healthcare

ResMed Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-04 20:41; UTC

Uždarbis
Pagrindinės rinkos jėgos

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

2025-12-04 18:14; UTC

Įsigijimai, susijungimai, perėmimai

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

2025-12-04 17:43; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

2025-12-04 17:01; UTC

Uždarbis

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

2025-12-04 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

2025-12-04 23:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-04 21:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-04 21:54; UTC

Rinkos pokalbiai

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

2025-12-04 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-12-04 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-04 21:48; UTC

Rinkos pokalbiai

Scales Hits Mark With Earnings Guidance -- Market Talk

2025-12-04 21:37; UTC

Uždarbis

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

2025-12-04 21:36; UTC

Uždarbis

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

2025-12-04 20:15; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-04 20:15; UTC

Rinkos pokalbiai

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

2025-12-04 20:04; UTC

Rinkos pokalbiai

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

2025-12-04 19:54; UTC

Rinkos pokalbiai

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

2025-12-04 19:44; UTC

Įsigijimai, susijungimai, perėmimai

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

2025-12-04 19:44; UTC

Įsigijimai, susijungimai, perėmimai

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

2025-12-04 19:44; UTC

Įsigijimai, susijungimai, perėmimai

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

2025-12-04 19:33; UTC

Rinkos pokalbiai

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

2025-12-04 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

2025-12-04 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

2025-12-04 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

2025-12-04 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

2025-12-04 18:58; UTC

Rinkos pokalbiai

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

2025-12-04 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-04 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-04 16:41; UTC

Rinkos pokalbiai

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

2025-12-04 16:33; UTC

Rinkos pokalbiai
Uždarbis

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

Akcijų palyginimas

Kainos pokytis

ResMed Inc Prognozė

Kainos tikslas

By TipRanks

20.3% į viršų

12 mėnesių prognozė

Vidutinis 302.56 USD  20.3%

Aukščiausias 335 USD

Žemiausias 270 USD

Remiantis 13 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ResMed Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

13 ratings

9

Pirkti

4

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

107 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat